(Q34149678)

English

Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

31 July 2017

Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci (English)

1 reference

stated in

Europe PubMed Central

31 July 2017

5

Mariana Castanheira

1 reference

stated in

Europe PubMed Central

31 July 2017

2

Helio S Sader

1 reference

stated in

Europe PubMed Central

31 July 2017

1

Shannon D Putnam

1 reference

stated in

Europe PubMed Central

31 July 2017

David J Farrell

3

1 reference

stated in

Europe PubMed Central

PubMed ID

21075602

retrieved

31 July 2017

Douglas J Biedenbach

series ordinal

4

1 reference

stated in

Europe PubMed Central

31 July 2017

1 January 2011

1 reference

stated in

Europe PubMed Central

31 July 2017

International Journal of Antimicrobial Agents

1 reference

stated in

Europe PubMed Central

31 July 2017

37

1 reference

stated in

Europe PubMed Central

31 July 2017

1

1 reference

stated in

Europe PubMed Central

31 July 2017

39-45

1 reference

stated in

Europe PubMed Central

PubMed ID

21075602

retrieved

31 July 2017

Identifiers

DOI

10.1016/J.IJANTIMICAG.2010.08.021

1 reference

stated in

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

PubMed ID

21075602

retrieved

31 July 2017

ResearchGate publication ID

47791032

0 references

(Q34149678)

Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)